
William E. Tapolcai
Examiner (ID: 12059)
| Most Active Art Unit | 3744 |
| Art Unit(s) | 3744, 3727, 2404, 2899, 3404 |
| Total Applications | 4297 |
| Issued Applications | 3670 |
| Pending Applications | 171 |
| Abandoned Applications | 456 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11176975
[patent_doc_number] => 09408950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Immobilised biological entities'
[patent_app_type] => utility
[patent_app_number] => 14/790205
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 22935
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/790205 | Immobilised biological entities | Jul 1, 2015 | Issued |
Array
(
[id] => 12191622
[patent_doc_number] => 09895333
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Enhanced bioavailability of polyunsaturated fatty acids'
[patent_app_type] => utility
[patent_app_number] => 14/749671
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 36446
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749671 | Enhanced bioavailability of polyunsaturated fatty acids | Jun 24, 2015 | Issued |
Array
(
[id] => 11527203
[patent_doc_number] => 20170087180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NITRIC OXIDE DEFICIENCY DISORDERS AND RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/315651
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21427
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/315651 | METHODS AND COMPOSITIONS FOR TREATING NITRIC OXIDE DEFICIENCY DISORDERS AND RELATED CONDITIONS | Jun 1, 2015 | Abandoned |
Array
(
[id] => 10380589
[patent_doc_number] => 20150265596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS'
[patent_app_type] => utility
[patent_app_number] => 14/717232
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7460
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717232
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/717232 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS | May 19, 2015 | Abandoned |
Array
(
[id] => 11864683
[patent_doc_number] => 20170231969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Pharmaceutical Compositions of Edoxaban'
[patent_app_type] => utility
[patent_app_number] => 15/501518
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2506
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501518
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501518 | Pharmaceutical Compositions of Edoxaban | May 12, 2015 | Abandoned |
Array
(
[id] => 10333175
[patent_doc_number] => 20150218179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'PARENTERAL FORMULATION FOR EPOTHILONE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 14/686005
[patent_app_country] => US
[patent_app_date] => 2015-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4447
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14686005
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/686005 | PARENTERAL FORMULATION FOR EPOTHILONE ANALOGS | Apr 13, 2015 | Abandoned |
Array
(
[id] => 10365730
[patent_doc_number] => 20150250733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'ORAL DRUG DELIVERY FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/685214
[patent_app_country] => US
[patent_app_date] => 2015-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 64949
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685214
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/685214 | ORAL DRUG DELIVERY FORMULATIONS | Apr 12, 2015 | Abandoned |
Array
(
[id] => 12259310
[patent_doc_number] => 20180078505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'PROCEDURE FOR PREPARING ENTERIC-COATED PELLETS CONTAINING A PROTON PUMP INHIBITOR AND MULTI-PARTICLE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 15/563181
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12770
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563181
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563181 | Procedure for preparing enteric-coated pellets containing a proton pump inhibitor and multi-particle pharmaceutical compositions containing them | Mar 30, 2015 | Issued |
Array
(
[id] => 11836258
[patent_doc_number] => 20170217976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => '6-(AMINO ACID)-MORPHINAN DERIVATIVES IN COMBINATION WITH PERMEATION ENHANCERS FOR USE AS AN ORALLY, RECTALLY, TRANSDERMALLY OR NASALLY ADMINISTERED MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 15/127681
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29318
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/127681 | 6-(AMINO ACID)-MORPHINAN DERIVATIVES IN COMBINATION WITH PERMEATION ENHANCERS FOR USE AS AN ORALLY, RECTALLY, TRANSDERMALLY OR NASALLY ADMINISTERED MEDICAMENT | Mar 22, 2015 | Abandoned |
Array
(
[id] => 10305518
[patent_doc_number] => 20150190519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA'
[patent_app_type] => utility
[patent_app_number] => 14/660872
[patent_app_country] => US
[patent_app_date] => 2015-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10465
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14660872
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/660872 | COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERPLASIA | Mar 16, 2015 | Abandoned |
Array
(
[id] => 10297541
[patent_doc_number] => 20150182540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/658533
[patent_app_country] => US
[patent_app_date] => 2015-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8774
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14658533
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/658533 | DROSPIRENONE FOR HORMONE REPLACEMENT THERAPY | Mar 15, 2015 | Abandoned |
Array
(
[id] => 11704714
[patent_doc_number] => 20170173213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'POLARIZED HYDROXYAPATITE FILMS AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/124401
[patent_app_country] => US
[patent_app_date] => 2015-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11007
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124401
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124401 | POLARIZED HYDROXYAPATITE FILMS AND METHODS OF MAKING AND USING SAME | Mar 9, 2015 | Abandoned |
Array
(
[id] => 10311586
[patent_doc_number] => 20150196588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/626571
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20084
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626571
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626571 | Pharmaceutical formulations of nitrite and uses thereof | Feb 18, 2015 | Issued |
Array
(
[id] => 10272554
[patent_doc_number] => 20150157551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'SKIN MOISTURIZER'
[patent_app_type] => utility
[patent_app_number] => 14/626710
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12121
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14626710
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/626710 | SKIN MOISTURIZER | Feb 18, 2015 | |
Array
(
[id] => 10346296
[patent_doc_number] => 20150231301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'METHOD OF TREATMENT OF DISSECTED LYMPH NODE AND/OR VESSEL'
[patent_app_type] => utility
[patent_app_number] => 14/625091
[patent_app_country] => US
[patent_app_date] => 2015-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4367
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14625091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/625091 | METHOD OF TREATMENT OF DISSECTED LYMPH NODE AND/OR VESSEL | Feb 17, 2015 | |
Array
(
[id] => 11954817
[patent_doc_number] => 20170258967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND'
[patent_app_type] => utility
[patent_app_number] => 15/118414
[patent_app_country] => US
[patent_app_date] => 2015-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 25914
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15118414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/118414 | COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND | Feb 12, 2015 | Abandoned |
Array
(
[id] => 10743293
[patent_doc_number] => 20160089443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'PROTEIN-GRAPHENE NANOCOMPOSITE DRUG CARRIER'
[patent_app_type] => utility
[patent_app_number] => 14/614391
[patent_app_country] => US
[patent_app_date] => 2015-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 12460
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14614391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/614391 | PROTEIN-GRAPHENE NANOCOMPOSITE DRUG CARRIER | Feb 3, 2015 | Abandoned |
Array
(
[id] => 10324339
[patent_doc_number] => 20150209343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'TOPICAL DERMAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/607531
[patent_app_country] => US
[patent_app_date] => 2015-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19665
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/607531 | TOPICAL DERMAL COMPOSITIONS | Jan 27, 2015 | |
Array
(
[id] => 11311756
[patent_doc_number] => 20160347866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'NOVEL ESTERIFIED CELLULOSE ETHERS OF HIGH MOLECULAR WEIGHT AND HOMOGENEITY'
[patent_app_type] => utility
[patent_app_number] => 15/113921
[patent_app_country] => US
[patent_app_date] => 2015-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12641
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113921
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/113921 | Esterified cellulose ethers of high molecular weight and homogeneity | Jan 26, 2015 | Issued |
Array
(
[id] => 10240410
[patent_doc_number] => 20150125405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'Methods For Improving Taste And Oral Care Compositions With Improved Taste'
[patent_app_type] => utility
[patent_app_number] => 14/594234
[patent_app_country] => US
[patent_app_date] => 2015-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10222
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594234
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/594234 | Methods For Improving Taste And Oral Care Compositions With Improved Taste | Jan 11, 2015 | Abandoned |